Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
NCT ID: NCT02051764
Last Updated: 2020-09-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
44 participants
INTERVENTIONAL
2014-05-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
18F-AV-1451 High Resolution Autopsy Study
NCT02350634
Flortaucipir 18F PET Imaging in BIOCARD Study
NCT03052972
A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
NCT03901092
Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
NCT01550549
Evaluation of Physician Training Methods to Read Florbetapir-PET Scans
NCT01565369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Follow-up Flortaucipir PET Scan
Flortaucipir F18
370 megabecquerel (MBq) IV single-dose
Florbetapir F 18
370 megabecquerel (MBq) IV single-dose
Brain PET Scan
positron emission tomography (PET) scan of the brain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flortaucipir F18
370 megabecquerel (MBq) IV single-dose
Florbetapir F 18
370 megabecquerel (MBq) IV single-dose
Brain PET Scan
positron emission tomography (PET) scan of the brain
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can tolerate up to two Positron Emission Tomography (PET) imaging sessions and a Magnetic Resonance Imaging (MRI) scan
* Ability to provide informed consent
Exclusion Criteria
* Are claustrophobic
* Current clinically significant cardiovascular disease or ECG abnormalities, or additional risk factors for Torsades de Pointes
* Current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer
* Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception
* Have had a non-study related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Avid Radiopharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chief Medical Officer
Role: STUDY_CHAIR
Avid Radiopharmaceuticals, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hoag Memorial Hospital
Newport Beach, California, United States
UC Irvine Medical Center
Orange, California, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Center for Clinical Imaging Research, Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18F-AV-1451-A04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.